Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Lactococcus rhamnosus (often referenced as Lactobacillus rhamnosus, particularly the GG strain) has been studied for its potential to support or treat constipation in children. The scientific evidence for its use is limited but present. Some randomized controlled trials (RCTs) and meta-analyses have explored the effects of various probiotics, including L. rhamnosus, on childhood constipation. For instance, a 2017 systematic review (Tabbers et al., J Pediatr Gastroenterol Nutr) concluded that there is insufficient evidence to recommend probiotics, including L. rhamnosus GG, for the treatment of functional constipation in children, as most studies did not show significant improvement in stool frequency or consistency compared to placebo. However, a few small studies have reported modest benefits in increasing stool frequency and improving stool consistency with certain probiotic strains, including L. rhamnosus GG, but these results are inconsistent and often not statistically significant. Current clinical guidelines do not recommend probiotics as a standard treatment for pediatric constipation. Thus, while there is some scientific investigation into the use of L. rhamnosus for this condition, the overall quality and consistency of evidence is low, and its use is not robustly supported by current scientific consensus.

More about Lactococcus rhamnosus
More about Constipation (children)

Other ingredients used for Constipation (children)

Other health conditions supported by Lactococcus rhamnosus

Products containing Lactococcus rhamnosus